Podcasts

Ed Pezalla, MD, MPH, chief executive officer of Enlightenment Bioconsult, LLC, provides insight on the drugs currently approved for the treatment of spinal muscular atrophy in the United States.

Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses why biomarker testing rates are low among patients with metastatic colorectal cancer, as well as what changes can be...

Keith Algozzine, founder and chief executive officer of UCM Digital Health, discusses how inflation is impacting the health care industry, areas of top concern, and how mobile health plays into the future of health care.

Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, shares how second generation BTK inhibitors are changing treatment decisions in chronic lymphocytic leukemia, and adds what payers should keep in mind...

Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, offers insight into how social determinants of health affect care access and quality for patients with atopic dermatitis.

Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, shares how severe atopic dermatitis impacts patients' quality of life, as well as what treatment challenges exist for this patient population.

Merle Diamond, MD, AQH, director, Diamond Headache Clinic and inpatient headache unit at Saint Joseph Hospital, offers insight into the prevalence and burden of migraine, as well as risk factors that can cause migraine to progress from...

Chad Worz, PharmD, BCGP, chief executive, ASCP, discusses the prevalence of polypharmacy among older adults with overactive bladder and the role pharmacists play in the care team to reduce the burden.